Mirxes Holding Co Ltd

Mirxes Holding Company Limited is a microRNA technology company that provides diagnostic solutions for screening cancer, cardiovascular, metabolic, and infectious diseases. Its offerings include GASTROClear, a blood-based miRNA panel with 12 biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening candidate; and Fortitude COVID-19 RT-qPCR test kits. The company also researches, develops, and manufactures biotechnology, life science, and medical science products. Founded in 2014, it is headquartered in Singapore and operates in Singapore and China.